Hospitals

Healthcare IT Market size is set to grow by USD 199.8 billion from 2024-2028, Increasing focus on improving quality of services and efficiency to boost the market growth, Technavio

Telehealth Market size is set to grow by USD 368.7 billion from 2024-2028, Increasing cases of chronic diseases boost the market, Technavio

NEW YORK, July 30, 2024 /PRNewswire/ -- The global telehealth market size is estimated to grow by USD 368.7 billion from...

Smart Healthcare Market size is set to grow by USD 115.39 billion from 2023-2027, Growing demand for remote health monitoring boost the market, Technavio

NEW YORK, July 30, 2024 /PRNewswire/ -- The global smart healthcare market size is estimated to grow by USD 115.39 billion from...

Digital Health Market size is set to grow by USD 1.06 billion from 2024-2028, Increase in the number of M and A activities in the market to boost the market growth, Technavio

Healthcare Information Software Market size is set to grow by USD 8.75 billion from 2024-2028, Increasing adoption of electronic health records to boost the market growth, Technavio

Providence Expands Engagement with Xsolis to Bring AI-Driven Operational Efficiencies to 28 Additional Hospitals in Six States, Advancing Patient-Centered Care

Successful implementation of Xsolis platform used data insights and predictive analytics to elevate work of clinical staff by reducing manual...

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C., and FREMONT, Calif., July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brainThese tools...

InflaRx to Present New Preclinical Data on INF904 at the 19th European Meeting on Complement in Human Diseases

JENA, Germany, July 30, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...

error: Content is protected !!